A
Axel Ullrich
Researcher at Max Planck Society
Publications - 436
Citations - 63142
Axel Ullrich is an academic researcher from Max Planck Society. The author has contributed to research in topics: Receptor tyrosine kinase & Tyrosine kinase. The author has an hindex of 124, co-authored 436 publications receiving 61445 citations. Previous affiliations of Axel Ullrich include Institute of Molecular and Cell Biology & Agency for Science, Technology and Research.
Papers
More filters
Journal ArticleDOI
Receptor protein tyrosine phosphatases are expressed by cycling retinal progenitor cells and involved in neuronal development of mouse retina
Andrea Horvat-Bröcker,Jacqueline Reinhard,S. Illes,T. Paech,Georg Zoidl,S. Harroch,C. Distler,Pjotr Knyazev,Axel Ullrich,Andreas Faissner +9 more
TL;DR: The results suggest distinct roles of RPTPs in cell proliferation and establishing phenotypes of different retinal cells during retinogenesis as well as later in the maintenance of mature retina.
Journal ArticleDOI
Expression, purification and crystallization of human phosphotyrosine phosphatase 1b
Edmund Hoppe,Pierre‐François Berne,Daniela Stock,Jesper Skou Rasmussen,Niels Møller,Axel Ullrich,Robert Huber +6 more
TL;DR: Thinner forms of PTP1B retained the same characteristics as the full-length mammalian enzyme, but are not subject to inhibition of enzymic activity mediated by the C-terminus, and it can be assumed that the catalytic domains are advantageous for crystallization studies in comparison to the natural enzyme.
Journal Article
Selection for transformation and met protooncogene amplification in NIH 3T3 fibroblasts using tumor necrosis factor alpha.
TL;DR: In this paper, the authors show that selection of NIH 3T3 fibroblasts for resistance to the cytotoxic effects of tumor necrosis factor alpha (TNF-alpha), a major mediator of macrophage-induced tumor cell cytotoxicity, leads to enrichment in the remaining cells for those with transformed morphology and is often associated with amplified copy number and expression of the met protooncogene.
Journal ArticleDOI
Metformin Triggers Autophagy to Attenuate Drug-Induced Apoptosis in NSCLC Cells, with Minor Effects on Tumors of Diabetic Patients
Zhiguang Xiao,Silvia Gaertner,Alicia Morresi-Hauf,Rebecca Genzel,Thomas Duell,Axel Ullrich,Pjotr Knyazev +6 more
TL;DR: In the retrospective study of 8 NSCLC patients, the administration of metformin did not induce statistically significant changes as assessed by immunohistochemical staining of pERK, pAKT and cleaved PARP.
Journal ArticleDOI
Effect of tumor-associated mutant E-cadherin variants with defects in exons 8 or 9 on matrix metalloproteinase 3
Margit Fuchs,Christine Hermannstädter,Katja Specht,Pjotr Knyazev,Axel Ullrich,Erika Rosivatz,Raymonde Busch,Peter Hutzler,Heinz Höfler,Birgit Luber +9 more
TL;DR: Application of the synthetic inhibitor of M MP‐3 NNGH and small interfering RNA directed against MMP‐3 reduce mutant E‐cadherin‐enhanced cell motility and point to a functional link between MMP•3 and E‐ cadher in.